Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blier

Showing results (31-40 of 229) with videos related to

Pageof 23
Sort By:
The International Journal of Neuropsychopharmacology|August 6, 2003
Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorderTarek Zghoul, Pierre Blier
Peptides|July 27, 2005
Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugsGabriella Gobbi, Pierre Blier
Neuropsychiatric Disease and Treatment|July 14, 2011
The noradrenergic symptom cluster: clinical expression and neuropharmacologyPierre Blier, Mike Briley
Current Drug Targets|February 16, 2006
Catecholaminergic strategies for the treatment of major depressionPhilippe Tremblay, Pierre Blier
European Journal of Pharmacology|October 22, 2008
Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactionsNasser Haddjeri, Pierre Blier
Journal of Clinical Psychopharmacology|February 21, 2013
Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case reportDaniel Zigman, Pierre Blier
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 24, 2006
Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorderMostafa El Mansari, Pierre Blier
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neuronsSteven T Szabo, Pierre Blier
The Journal of Clinical Psychiatry|December 13, 2005
Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxietyPierre Blier, Steve T Szabo
Journal of Psychiatry & Neuroscience : JPN|October 19, 2023
Does serotonin matter in depression?Paul R Albert, Pierre Blier
Pageof 23

Showing results (31-40 of 229) with videos related to

Sort By:
Pageof 23
The International Journal of Neuropsychopharmacology|August 6, 2003
Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorderTarek Zghoul, Pierre Blier
Peptides|July 27, 2005
Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugsGabriella Gobbi, Pierre Blier
Neuropsychiatric Disease and Treatment|July 14, 2011
The noradrenergic symptom cluster: clinical expression and neuropharmacologyPierre Blier, Mike Briley
Current Drug Targets|February 16, 2006
Catecholaminergic strategies for the treatment of major depressionPhilippe Tremblay, Pierre Blier
European Journal of Pharmacology|October 22, 2008
Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactionsNasser Haddjeri, Pierre Blier
Journal of Clinical Psychopharmacology|February 21, 2013
Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case reportDaniel Zigman, Pierre Blier
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 24, 2006
Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorderMostafa El Mansari, Pierre Blier
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neuronsSteven T Szabo, Pierre Blier
The Journal of Clinical Psychiatry|December 13, 2005
Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxietyPierre Blier, Steve T Szabo
Journal of Psychiatry & Neuroscience : JPN|October 19, 2023
Does serotonin matter in depression?Paul R Albert, Pierre Blier
Pageof 23